nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Muscle strain—Metformin—polycystic ovary syndrome	0.0476	0.0801	CcSEcCtD
Tramadol—White blood cell count increased—Metformin—polycystic ovary syndrome	0.0297	0.05	CcSEcCtD
Tramadol—Seasonal allergy—Metformin—polycystic ovary syndrome	0.0285	0.0479	CcSEcCtD
Tramadol—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.0273	0.046	CcSEcCtD
Tramadol—Angina unstable—Metformin—polycystic ovary syndrome	0.0236	0.0398	CcSEcCtD
Tramadol—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.0229	0.0385	CcSEcCtD
Tramadol—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0209	0.0351	CcSEcCtD
Tramadol—Sinus headache—Metformin—polycystic ovary syndrome	0.0183	0.0308	CcSEcCtD
Tramadol—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0167	0.0281	CcSEcCtD
Tramadol—Tooth abscess—Metformin—polycystic ovary syndrome	0.0143	0.024	CcSEcCtD
Tramadol—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0125	0.0211	CcSEcCtD
Tramadol—Sinus congestion—Metformin—polycystic ovary syndrome	0.012	0.0202	CcSEcCtD
Tramadol—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0114	0.0191	CcSEcCtD
Tramadol—Loose stools—Metformin—polycystic ovary syndrome	0.0108	0.0181	CcSEcCtD
Tramadol—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0102	0.0171	CcSEcCtD
Tramadol—Toothache—Metformin—polycystic ovary syndrome	0.00981	0.0165	CcSEcCtD
Tramadol—Upset stomach—Metformin—polycystic ovary syndrome	0.00911	0.0153	CcSEcCtD
Tramadol—Fungal infection—Metformin—polycystic ovary syndrome	0.00773	0.013	CcSEcCtD
Tramadol—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00737	0.0124	CcSEcCtD
Tramadol—Rigors—Metformin—polycystic ovary syndrome	0.00731	0.0123	CcSEcCtD
Tramadol—Contusion—Metformin—polycystic ovary syndrome	0.00684	0.0115	CcSEcCtD
Tramadol—Chest discomfort—Metformin—polycystic ovary syndrome	0.00675	0.0114	CcSEcCtD
Tramadol—Accidental injury—Metformin—polycystic ovary syndrome	0.00675	0.0114	CcSEcCtD
Tramadol—Ear pain—Metformin—polycystic ovary syndrome	0.00508	0.00854	CcSEcCtD
Tramadol—Nasal congestion—Metformin—polycystic ovary syndrome	0.00476	0.008	CcSEcCtD
Tramadol—Injury—Metformin—polycystic ovary syndrome	0.00471	0.00793	CcSEcCtD
Tramadol—Renal impairment—Metformin—polycystic ovary syndrome	0.00455	0.00766	CcSEcCtD
Tramadol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00444	0.00747	CcSEcCtD
Tramadol—Lethargy—Metformin—polycystic ovary syndrome	0.00442	0.00744	CcSEcCtD
Tramadol—Pain in extremity—Metformin—polycystic ovary syndrome	0.00433	0.00729	CcSEcCtD
Tramadol—Migraine—Metformin—polycystic ovary syndrome	0.00427	0.00718	CcSEcCtD
Tramadol—Dehydration—Metformin—polycystic ovary syndrome	0.00403	0.00678	CcSEcCtD
Tramadol—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.004	0.00673	CcSEcCtD
Tramadol—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00396	0.00666	CcSEcCtD
Tramadol—Breast disorder—Metformin—polycystic ovary syndrome	0.00392	0.00659	CcSEcCtD
Tramadol—Cramp muscle—Metformin—polycystic ovary syndrome	0.0039	0.00656	CcSEcCtD
Tramadol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00387	0.00652	CcSEcCtD
Tramadol—Abdominal distension—Metformin—polycystic ovary syndrome	0.00377	0.00634	CcSEcCtD
Tramadol—Influenza—Metformin—polycystic ovary syndrome	0.00375	0.0063	CcSEcCtD
Tramadol—Pancreatitis—Metformin—polycystic ovary syndrome	0.00367	0.00618	CcSEcCtD
Tramadol—Angina pectoris—Metformin—polycystic ovary syndrome	0.00365	0.00614	CcSEcCtD
Tramadol—Sweating increased—Metformin—polycystic ovary syndrome	0.00365	0.00614	CcSEcCtD
Tramadol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00359	0.00604	CcSEcCtD
Tramadol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00348	0.00586	CcSEcCtD
Tramadol—Infestation NOS—Metformin—polycystic ovary syndrome	0.00334	0.00562	CcSEcCtD
Tramadol—Infestation—Metformin—polycystic ovary syndrome	0.00334	0.00562	CcSEcCtD
Tramadol—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00316	0.00531	CcSEcCtD
Tramadol—Bradycardia—Metformin—polycystic ovary syndrome	0.00305	0.00513	CcSEcCtD
Tramadol—Rhinitis—Metformin—polycystic ovary syndrome	0.00301	0.00506	CcSEcCtD
Tramadol—Hepatitis—Metformin—polycystic ovary syndrome	0.003	0.00504	CcSEcCtD
Tramadol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00298	0.00502	CcSEcCtD
Tramadol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00295	0.00497	CcSEcCtD
Tramadol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00295	0.00496	CcSEcCtD
Tramadol—Eye disorder—Metformin—polycystic ovary syndrome	0.0028	0.00471	CcSEcCtD
Tramadol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00278	0.00468	CcSEcCtD
Tramadol—Flushing—Metformin—polycystic ovary syndrome	0.00278	0.00468	CcSEcCtD
Tramadol—Angiopathy—Metformin—polycystic ovary syndrome	0.00272	0.00458	CcSEcCtD
Tramadol—Immune system disorder—Metformin—polycystic ovary syndrome	0.00271	0.00456	CcSEcCtD
Tramadol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0027	0.00455	CcSEcCtD
Tramadol—Chills—Metformin—polycystic ovary syndrome	0.00269	0.00453	CcSEcCtD
Tramadol—Erythema—Metformin—polycystic ovary syndrome	0.00261	0.00439	CcSEcCtD
Tramadol—Malnutrition—Metformin—polycystic ovary syndrome	0.00261	0.00439	CcSEcCtD
Tramadol—Flatulence—Metformin—polycystic ovary syndrome	0.00257	0.00433	CcSEcCtD
Tramadol—Dysgeusia—Metformin—polycystic ovary syndrome	0.00256	0.0043	CcSEcCtD
Tramadol—Muscle spasms—Metformin—polycystic ovary syndrome	0.00251	0.00422	CcSEcCtD
Tramadol—Vision blurred—Metformin—polycystic ovary syndrome	0.00246	0.00414	CcSEcCtD
Tramadol—Tremor—Metformin—polycystic ovary syndrome	0.00244	0.00411	CcSEcCtD
Tramadol—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00242	0.00407	CcSEcCtD
Tramadol—Malaise—Metformin—polycystic ovary syndrome	0.00235	0.00396	CcSEcCtD
Tramadol—Syncope—Metformin—polycystic ovary syndrome	0.00234	0.00394	CcSEcCtD
Tramadol—Palpitations—Metformin—polycystic ovary syndrome	0.00231	0.00388	CcSEcCtD
Tramadol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00229	0.00386	CcSEcCtD
Tramadol—Hypertension—Metformin—polycystic ovary syndrome	0.00225	0.00379	CcSEcCtD
Tramadol—Chest pain—Metformin—polycystic ovary syndrome	0.00222	0.00374	CcSEcCtD
Tramadol—Myalgia—Metformin—polycystic ovary syndrome	0.00222	0.00374	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00221	0.00371	CcSEcCtD
Tramadol—Discomfort—Metformin—polycystic ovary syndrome	0.00219	0.00369	CcSEcCtD
Tramadol—Infection—Metformin—polycystic ovary syndrome	0.00212	0.00356	CcSEcCtD
Tramadol—Shock—Metformin—polycystic ovary syndrome	0.0021	0.00353	CcSEcCtD
Tramadol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00209	0.00351	CcSEcCtD
Tramadol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00209	0.00351	CcSEcCtD
Tramadol—Skin disorder—Metformin—polycystic ovary syndrome	0.00207	0.00348	CcSEcCtD
Tramadol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00206	0.00346	CcSEcCtD
Tramadol—Anorexia—Metformin—polycystic ovary syndrome	0.00203	0.00342	CcSEcCtD
Tramadol—Hypotension—Metformin—polycystic ovary syndrome	0.00199	0.00335	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00194	0.00326	CcSEcCtD
Tramadol—Paraesthesia—Metformin—polycystic ovary syndrome	0.00191	0.00322	CcSEcCtD
Tramadol—Dyspnoea—Metformin—polycystic ovary syndrome	0.0019	0.00319	CcSEcCtD
Tramadol—Somnolence—Metformin—polycystic ovary syndrome	0.00189	0.00319	CcSEcCtD
Tramadol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00187	0.00315	CcSEcCtD
Tramadol—Decreased appetite—Metformin—polycystic ovary syndrome	0.00185	0.00311	CcSEcCtD
Tramadol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00184	0.00309	CcSEcCtD
Tramadol—Fatigue—Metformin—polycystic ovary syndrome	0.00184	0.00309	CcSEcCtD
Tramadol—Constipation—Metformin—polycystic ovary syndrome	0.00182	0.00306	CcSEcCtD
Tramadol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00175	0.00295	CcSEcCtD
Tramadol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00174	0.00293	CcSEcCtD
Tramadol—Urticaria—Metformin—polycystic ovary syndrome	0.00169	0.00285	CcSEcCtD
Tramadol—Abdominal pain—Metformin—polycystic ovary syndrome	0.00168	0.00283	CcSEcCtD
Tramadol—Asthenia—Metformin—polycystic ovary syndrome	0.00153	0.00257	CcSEcCtD
Tramadol—Pruritus—Metformin—polycystic ovary syndrome	0.00151	0.00254	CcSEcCtD
Tramadol—Diarrhoea—Metformin—polycystic ovary syndrome	0.00146	0.00245	CcSEcCtD
Tramadol—Dizziness—Metformin—polycystic ovary syndrome	0.00141	0.00237	CcSEcCtD
Tramadol—Vomiting—Metformin—polycystic ovary syndrome	0.00135	0.00228	CcSEcCtD
Tramadol—Rash—Metformin—polycystic ovary syndrome	0.00134	0.00226	CcSEcCtD
Tramadol—Dermatitis—Metformin—polycystic ovary syndrome	0.00134	0.00226	CcSEcCtD
Tramadol—Headache—Metformin—polycystic ovary syndrome	0.00133	0.00224	CcSEcCtD
Tramadol—Nausea—Metformin—polycystic ovary syndrome	0.00127	0.00213	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	9.37e-05	0.000231	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	9.31e-05	0.00023	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.19e-05	0.000227	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	9.16e-05	0.000226	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	9.16e-05	0.000226	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.14e-05	0.000225	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	9.11e-05	0.000225	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	9.11e-05	0.000225	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	9.03e-05	0.000223	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	9e-05	0.000222	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	8.99e-05	0.000222	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	8.92e-05	0.00022	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	8.88e-05	0.000219	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	8.84e-05	0.000218	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	8.84e-05	0.000218	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	8.83e-05	0.000218	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.82e-05	0.000217	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.78e-05	0.000216	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.77e-05	0.000216	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	8.77e-05	0.000216	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	8.74e-05	0.000216	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.74e-05	0.000215	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	8.73e-05	0.000215	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.72e-05	0.000215	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.72e-05	0.000215	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	8.71e-05	0.000215	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	8.67e-05	0.000214	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.64e-05	0.000213	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	8.63e-05	0.000213	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.54e-05	0.000211	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.52e-05	0.00021	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.48e-05	0.000209	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	8.47e-05	0.000209	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	8.44e-05	0.000208	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	8.43e-05	0.000208	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.41e-05	0.000207	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	8.38e-05	0.000207	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	8.32e-05	0.000205	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	8.2e-05	0.000202	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	8.19e-05	0.000202	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	8.19e-05	0.000202	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	8.12e-05	0.0002	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.11e-05	0.0002	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	8.1e-05	0.0002	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.08e-05	0.000199	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	8.07e-05	0.000199	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	8.06e-05	0.000199	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	8.02e-05	0.000198	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.01e-05	0.000198	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	8.01e-05	0.000197	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	8e-05	0.000197	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	7.99e-05	0.000197	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	7.99e-05	0.000197	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	7.77e-05	0.000191	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.75e-05	0.000191	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	7.74e-05	0.000191	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	7.74e-05	0.000191	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	7.72e-05	0.00019	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.7e-05	0.00019	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.64e-05	0.000188	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	7.61e-05	0.000188	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.58e-05	0.000187	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	7.55e-05	0.000186	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	7.55e-05	0.000186	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	7.52e-05	0.000185	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	7.52e-05	0.000185	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.49e-05	0.000185	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.46e-05	0.000184	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	7.44e-05	0.000183	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.43e-05	0.000183	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	7.38e-05	0.000182	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.34e-05	0.000181	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	7.25e-05	0.000179	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	7.22e-05	0.000178	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.2e-05	0.000177	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.17e-05	0.000177	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	7.15e-05	0.000176	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	7.12e-05	0.000176	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	7.05e-05	0.000174	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	7.03e-05	0.000173	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	6.97e-05	0.000172	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	6.95e-05	0.000171	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.89e-05	0.00017	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.89e-05	0.00017	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	6.88e-05	0.00017	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	6.81e-05	0.000168	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	6.8e-05	0.000168	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	6.77e-05	0.000167	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	6.75e-05	0.000166	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.7e-05	0.000165	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	6.65e-05	0.000164	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	6.65e-05	0.000164	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	6.65e-05	0.000164	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.57e-05	0.000162	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.51e-05	0.00016	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	6.5e-05	0.00016	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TH—polycystic ovary syndrome	6.43e-05	0.000159	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.42e-05	0.000158	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.41e-05	0.000158	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.4e-05	0.000158	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	6.4e-05	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	6.34e-05	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.32e-05	0.000156	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	6.28e-05	0.000155	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	6.26e-05	0.000154	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.22e-05	0.000153	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	6.2e-05	0.000153	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.18e-05	0.000152	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	6.15e-05	0.000152	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.15e-05	0.000152	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	6.06e-05	0.000149	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.94e-05	0.000146	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	5.88e-05	0.000145	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	5.87e-05	0.000145	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	5.85e-05	0.000144	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	5.81e-05	0.000143	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	5.8e-05	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.78e-05	0.000142	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	5.72e-05	0.000141	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	5.72e-05	0.000141	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.66e-05	0.000139	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.63e-05	0.000139	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.6e-05	0.000138	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.59e-05	0.000138	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.55e-05	0.000137	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TH—polycystic ovary syndrome	5.53e-05	0.000136	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.51e-05	0.000136	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	5.51e-05	0.000136	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.5e-05	0.000136	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.48e-05	0.000135	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	5.46e-05	0.000135	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	5.4e-05	0.000133	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	5.4e-05	0.000133	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	5.38e-05	0.000133	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	5.37e-05	0.000132	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.32e-05	0.000131	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.3e-05	0.000131	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	5.25e-05	0.000129	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	5.23e-05	0.000129	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.23e-05	0.000129	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.19e-05	0.000128	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.19e-05	0.000128	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	5.1e-05	0.000126	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	5.06e-05	0.000125	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	5.04e-05	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	5.04e-05	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	5.01e-05	0.000123	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	5e-05	0.000123	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	4.99e-05	0.000123	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.93e-05	0.000122	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.91e-05	0.000121	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.86e-05	0.00012	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.84e-05	0.000119	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.81e-05	0.000119	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4.78e-05	0.000118	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.77e-05	0.000118	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.76e-05	0.000117	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	4.74e-05	0.000117	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.74e-05	0.000117	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	4.73e-05	0.000117	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	4.71e-05	0.000116	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.66e-05	0.000115	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	4.66e-05	0.000115	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.55e-05	0.000112	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.55e-05	0.000112	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	4.52e-05	0.000111	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.52e-05	0.000111	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.45e-05	0.00011	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.44e-05	0.00011	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	4.42e-05	0.000109	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	4.39e-05	0.000108	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.32e-05	0.000107	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	4.3e-05	0.000106	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.18e-05	0.000103	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.15e-05	0.000102	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	4.11e-05	0.000101	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.09e-05	0.000101	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	4.08e-05	0.000101	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.05e-05	9.99e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	4e-05	9.86e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	4e-05	9.86e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	3.98e-05	9.8e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.97e-05	9.79e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.96e-05	9.76e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.85e-05	9.48e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.85e-05	9.48e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.84e-05	9.48e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.84e-05	9.45e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	3.8e-05	9.38e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.74e-05	9.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.65e-05	9.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	3.59e-05	8.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.57e-05	8.79e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—polycystic ovary syndrome	3.54e-05	8.72e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.53e-05	8.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.52e-05	8.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	3.52e-05	8.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—INS—polycystic ovary syndrome	3.52e-05	8.67e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.48e-05	8.58e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	3.44e-05	8.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.43e-05	8.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.42e-05	8.43e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.42e-05	8.42e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.39e-05	8.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.3e-05	8.14e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.3e-05	8.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.3e-05	8.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.17e-05	7.8e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.14e-05	7.74e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.14e-05	7.73e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.13e-05	7.71e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	3.08e-05	7.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	3.07e-05	7.57e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	3.04e-05	7.5e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—INS—polycystic ovary syndrome	3.03e-05	7.46e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.99e-05	7.37e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.97e-05	7.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.96e-05	7.29e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.95e-05	7.28e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.94e-05	7.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	2.94e-05	7.25e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.91e-05	7.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.84e-05	7.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.84e-05	7.01e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.84e-05	6.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.7e-05	6.66e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.64e-05	6.52e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.53e-05	6.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.51e-05	6.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.51e-05	6.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.45e-05	6.03e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	2.35e-05	5.78e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.3e-05	5.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.18e-05	5.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.16e-05	5.32e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.14e-05	5.29e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.11e-05	5.21e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.1e-05	5.18e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	2.06e-05	5.07e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.05e-05	5.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.96e-05	4.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.86e-05	4.58e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.85e-05	4.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.74e-05	4.28e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.73e-05	4.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.49e-05	3.68e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.4e-05	3.46e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.38e-05	3.41e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.37e-05	3.39e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.28e-05	3.17e-05	CbGpPWpGaD
